These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 31370155)
1. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. Russi S; Verma HK; Laurino S; Mazzone P; Storto G; Nardelli A; Zoppoli P; Calice G; La Rocca F; Sgambato A; Lucci V; Falco G; Ruggieri V Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370155 [TBL] [Abstract][Full Text] [Related]
2. The Microenvironment of Lung Cancer and Therapeutic Implications. Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800 [TBL] [Abstract][Full Text] [Related]
3. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition. Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566 [TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles in lung cancer-From bench to bedside. Kadota T; Yoshioka Y; Fujita Y; Kuwano K; Ochiya T Semin Cell Dev Biol; 2017 Jul; 67():39-47. PubMed ID: 28267596 [TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy. Spirina LV; Avgustinovich AV; Afanas'ev SG; Cheremisina OV; Volkov MY; Choynzonov EL; Gorbunov AK; Usynin EA Curr Drug Targets; 2020; 21(7):713-721. PubMed ID: 31775598 [TBL] [Abstract][Full Text] [Related]
6. Heparanase: From basic research to therapeutic applications in cancer and inflammation. Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844 [TBL] [Abstract][Full Text] [Related]
7. miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1. Huang H; Tang J; Zhang L; Bu Y; Zhang X Int J Oncol; 2018 Dec; 53(6):2769-2779. PubMed ID: 30320370 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway. Ou Y; Ren H; Zhao R; Song L; Liu Z; Xu W; Liu Y; Wang S Mol Carcinog; 2019 Aug; 58(8):1427-1437. PubMed ID: 31162747 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2. Kang DW; Yang ES; Noh YN; Hwang WC; Jo SY; Suh YA; Park WS; Choi KY; Min DS J Pathol; 2017 Apr; 241(5):614-625. PubMed ID: 28008607 [TBL] [Abstract][Full Text] [Related]
10. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer. Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer. Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925 [TBL] [Abstract][Full Text] [Related]
13. SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment. Qiu G; Li X; Che X; Wei C; He S; Lu J; Jia Z; Pang K; Fan L FEBS Lett; 2015 Jul; 589(16):2034-42. PubMed ID: 26049033 [TBL] [Abstract][Full Text] [Related]
14. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2. Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840 [TBL] [Abstract][Full Text] [Related]
15. Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance. Santos P; Almeida F Cells; 2020 Jun; 9(6):. PubMed ID: 32545155 [TBL] [Abstract][Full Text] [Related]
16. Targeting hypoxic tumor microenvironment in pancreatic cancer. Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044 [TBL] [Abstract][Full Text] [Related]
17. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer. Riquelme I; Letelier P; Riffo-Campos AL; Brebi P; Roa JC Int J Mol Sci; 2016 Mar; 17(3):424. PubMed ID: 27011182 [TBL] [Abstract][Full Text] [Related]
18. Endothelial cell autophagy in homeostasis and cancer. Verhoeven J; Baelen J; Agrawal M; Agostinis P FEBS Lett; 2021 Jun; 595(11):1497-1511. PubMed ID: 33837545 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells. Wang M; Zhang R; Zhang S; Xu R; Yang Q Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930 [TBL] [Abstract][Full Text] [Related]
20. Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer. Oshi M; Roy AM; Yan L; Kinoshita S; Tamura Y; Kosaka T; Akiyama H; Kunisaki C; Takabe K; Endo I Cancer Gene Ther; 2024 May; 31(5):746-754. PubMed ID: 38532115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]